ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

476
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
24 Mar 2020 07:30

Celltrion Seo's Projected Timeline for a COVID-19 Vaccine: Key Takeaways from PR

The three Celltrion siblings had quite a pleasant day yesterday. Celltrion Inc (068270 KS) was up 14.75%, while Celltrion Pharm (068760 KS) almost...

Logo
304 Views
Share
17 Mar 2020 17:37

Short Selling - The Last Hurrah

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 13 March 2020, the...

Logo
334 Views
Share
15 Mar 2020 18:08

The Short Sell Ban Is Here

After tinkering with changes to the short sell rules, the Financial Services Commission (FSC) finally imposed a ban on short selling in the KOSPI,...

Logo
370 Views
Share
10 Mar 2020 18:04

FSC Tweaks Short Sell Rules; Shorts Jump on Samsung Electronics, KT&G, Hyundai Motors

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 6 March 2020.Current...

Logo
341 Views
Share
09 Mar 2020 10:30

Korea's Low Dividend Stocks Facing Pressure From Institutional Investors

Korean companies have historically carried fairly low dividend yields, which is one of the key factors driving the so-called "Korea Discount". As...

Logo
364 Views
Share
x